Chemed (NYSE:CHE) Posts Earnings Results, Beats Expectations By $0.46 EPS

Chemed (NYSE:CHE) issued its quarterly earnings data on Tuesday. The company reported $6.06 EPS for the quarter, topping the consensus estimate of $5.60 by $0.46, FiscalAI reports. The business had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The firm’s revenue was up 8.8% compared to the same quarter last year. During the same quarter last year, the business posted $4.27 EPS. Chemed updated its FY 2026 guidance to 25.000-25.750 EPS.

Chemed Stock Up 1.3%

Shares of Chemed stock traded up $6.75 during trading on Tuesday, reaching $516.09. The stock had a trading volume of 198,346 shares, compared to its average volume of 153,282. The company has a current ratio of 0.85, a quick ratio of 0.83 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $6.85 billion, a price-to-earnings ratio of 25.87, a P/E/G ratio of 1.88 and a beta of 0.52. The stock has a fifty day moving average price of $461.43 and a two-hundred day moving average price of $434.63. Chemed has a 52 week low of $365.20 and a 52 week high of $520.01.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, May 28th. Chemed’s payout ratio is 13.08%.

Insider Transactions at Chemed

In related news, Director Andrea R. Lindell sold 1,347 shares of the stock in a transaction dated Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 3.33% of the stock is currently owned by company insiders.

Institutional Trading of Chemed

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Commonwealth Equity Services LLC lifted its position in shares of Chemed by 3.1% in the fourth quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after purchasing an additional 22 shares in the last quarter. Cim LLC increased its stake in Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after buying an additional 24 shares during the last quarter. Merit Financial Group LLC lifted its position in Chemed by 4.0% during the 3rd quarter. Merit Financial Group LLC now owns 940 shares of the company’s stock worth $421,000 after buying an additional 36 shares in the last quarter. Deutsche Bank AG lifted its position in Chemed by 1.2% during the 4th quarter. Deutsche Bank AG now owns 2,929 shares of the company’s stock worth $1,253,000 after buying an additional 36 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its stake in shares of Chemed by 0.8% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 5,007 shares of the company’s stock worth $2,242,000 after buying an additional 40 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on CHE shares. Royal Bank Of Canada increased their price target on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Wall Street Zen lowered Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. Bank of America increased their target price on Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a research note on Thursday, July 9th. Finally, Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $480.25.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.